Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

Comparing treatments for early missed abortion

Official title: A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion

Run by The Third Xiangya Hospital of Central South University · NCT07422506 · Data updated 2026-11-12

This project will see if different treatment methods and estrogen doses help people with early missed abortion recover safely and reduce complications.

More Early Pregnancy trials

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment580 (estimated)
SponsorThe Third Xiangya Hospital of Central South University
Academic / other
Locations1 site (Changsha, Hunan)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2035
Registry record updatedFebruary 20, 2026
Trial IDNCT07422506 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 18–40 with imaging- and lab-confirmed early missed abortion, normal routine exam results, no need for emergency curettage, and the ability to attend follow-up are the intended participants.

Probably not a fit

Patients with contraindications to medical abortion or estrogen, heavy vaginal bleeding, thromboembolic disease, hormone-dependent tumors, severe organ disease, or inability to follow up are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research collects clinical data to compare surgical versus medical management for early missed abortion and tracks reproductive outcomes. It has two parts: a retrospective analysis comparing past cases of surgery and drug treatment, and a prospective phase testing different estrogen doses combined with either surgery or medical induction. Investigators will compare treatment success rates, complication rates, and subsequent fertility outcomes using statistical analyses. The aim is to find regimens that achieve complete uterine evacuation with fewer complications and clearer guidance on estrogen dosing.

Why it matters

Potential benefit: If successful, the results could identify treatment approaches that lower complication rates and improve reproductive outcomes after early missed abortion.

How similar studies have gone: Previous research has compared surgical and medical management for missed abortion, but using high-dose estrogen as an adjunct is less well studied and evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ①Age 18-40 years old; ②Early pregnancy missed abortion confirmed by imaging and laboratory tests; ③All indicators of routine examinations before treatment are within the normal range, and there are no serious systemic diseases; ④No indications for emergency curettage; ⑤Good compliance, follow-up observation as required (prospective study).

Exclusion Criteria:

* ①Contraindications to medical abortion; ②Those who are allergic to estrogen and have contraindications to the use of estrogen; ③Those who cannot be followed up according to the follow-up plan; ④Thromboembolic diseases, known or suspected history of breast cancer, hormone-dependent tumors, etc.; ⑤Vaginal bleeding exceeds the usual menstrual volume; ⑥Those with severe heart, liver and kidney diseases; ⑦Accompanied by serious internal and surgical diseases, malignant tumors or mental illnesses, and cannot cooperate.

Where it's running

  • The Third Xiangya Hospital of Central South University
    Changsha, Hunan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.